Pricing
  1. JP-listed companies
  2. ADR120S, Inc.
  3. Financials
  4. Net income margin (%)

ADR120S, Inc.【JP:3750】

Market cap
¥7.9B
P/E ratio
110.7x
Saitori Cell Research Institute develops regenerative cell therapies and medical devices while also investing in real estate projects through seven subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 2025-1,751.2-19767.73%
Mar 31, 20248.9-118.02%
Mar 31, 2023-49.4+756.00%
Mar 31, 2022-5.8-89.67%
Mar 31, 2021-55.9-306.43%
Mar 31, 202027.1-12.14%
Mar 31, 201930.8-64.26%
Mar 31, 201886.2-599.81%
Mar 31, 2017-17.2-1456.15%
Mar 31, 20161.3-57.12%
Mar 31, 20153-285.60%
Mar 31, 2014-1.6-50.03%
Mar 31, 2013-3.2-73.46%
Mar 31, 2012-12

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)